Thursday Feb 9 | Freshnews
Ligand to Present at the Bio Ceo and Investor Conference on February 13
The conference takes place at Waldorf-Astoria in New York. A live webcast of the presentation will be available on the Company's website www.ligand.com . A replay of the presentation will be archived on the site for 30 days.
Ligand Pharmaceuticals Crushes Estimates
The 10-second takeaway For the quarter ended Dec. 31 , Ligand Pharmaceuticals crushed expectations on revenue and beat expectations on earnings per share.
Ligand Appoints Corporate Development VP
Nishan de Silva, M.D. , has been appointed vice president of corporate development at Ligand Pharmaceuticals .
Ligand Presents Full Data from Successful Phase II Trial of...
Ligand Pharmaceuticals Incorporated announced that results from the Phase II study of its Captisol-enabled, propylene glycol-free Melphalan program were featured this evening in a poster presentation at the combined annual meetings of the Center for International Blood & Marrow Transplant Research and the American Society for Blood and Marrow ... (more)
Ligand to Report Fourth Quarter Results on February 7
Ligand Pharmaceuticals Incorporated announced today that its fourth quarter 2011 earnings release will be issued after market close on Tuesday, February 7, 2012.
New Stock Coverage to Watch in January
Ligand Pharma : Summer Street Research initiated coverage of this company with a rating of Buy and a price target of $22. Dice Holdings : Northland Securities initiated coverage of this company with a rating of Outperform and a price target of $12. Hackett Group : Northland Securities initiated coverage of this company with a rating of Outperform ... (more)
Also on Topix